Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
PharmaBoardroom - Charles-Henri Bodin - General Manager, Pierre Fabre Italy
Pierre Fabre signs on second partner to innovation program
Developing the medical treatments of tomorrow: Pierre Fabre Pharma R&D
Pierre Fabre | A French pharmaceutical and dermocosmetics group
Our Pharmaceutical Laboratory : an International Company | Pierre Fabre
Pierre Fabre Pharma - Feelfine - Incentive and Event
Bormioli Pharma, Pierre Fabre Develop New PET Packaging | Healthcare Packaging
Rx Item-Hemangeol 4.28Mg/Ml Solution 120Ml By Pierre Fabre Pharma
Making a model for ethical pharma work in the real world
France's 2nd Biggest Pharma Enters New Partnership for Immunotherapies
Pierre Fabre to cut jobs in pharma to focus on cosmetics division abroad
All About the Pharmaceutical and Dermocosmetics Group, Pierre Fabre
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
PIERRE FABRE PHARMA NORDEN AB | LinkedIn
Pierre Fabre, French pharmaceutical and dermocosmetics group
Groupe Pierre Fabre - Company Profile - Global Cosmetics News
Laboratoires Pierre Fabre - Wikipedia
